United States 114th Congress Status: Died 1 D cosponsors

HR 2241 — Global Health Innovation Act of 2015

Last action — Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Global Health Innovation Act of 2015 (Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding: the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations; how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; how goals are set for health product development in relation to USAID's health-related goals; how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline; how USAID is coordinating with other federal departments and agencies in support of global health product development; and how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 2241 on the official United States source →

Action History

  1. Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

  2. Motion to reconsider laid on the table Agreed to without objection.

  3. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 12/16/2015 H9348)

  4. Considered as unfinished business. (consideration: CR H10696)

  5. At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Royce objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  6. DEBATE - The House proceeded with forty minutes of debate on H.R. 2241.

  7. Considered under suspension of the rules. (consideration: CR H9348-9349; text of measure as introduced: CR H9348)

  8. Mr. Royce moved to suspend the rules and pass the bill, as amended.

  9. Ordered to be Reported (Amended) by Unanimous Consent.

  10. Committee Consideration and Mark-up Session Held.

  11. Referred to the House Committee on Foreign Affairs.

  12. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

immigration healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 2241 do?
Global Health Innovation Act of 2015 (Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding: the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations; how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; how goals are set for health product development in relation to USAID's health-related goals; how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline; how USAID is coordinating with other federal departments and agencies in support of global health product development; and how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.
Who sponsors HR 2241?
HR 2241 is sponsored by Albio Sires (D).
What is the current status of HR 2241?
This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 2241?
Track HR 2241 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 2241

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 2241

Last checked for changes about 15 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →